SCHEMBL4841575

SCHEMBL4841575

COC(=O)c1ccc(NCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3cc(C(F)(F)F)ccc3Cl)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.39
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
RORC P51449 1/20 0.37
MAPK14 Q16539 1/20 0.37
MMP8 P22894 4/20 0.36
MMP3 P08254 2/20 0.36
GNRHR P30968 2/20 0.36
IL2 P60568 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
POLB P06746 1/20 0.36
MITF O75030 1/20 0.35
ALOX5 P09917 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4837871 0.94 MAPT (0.38) MAPTPSEN1PSEN2APH1BNCSTN
SCHEMBL4834001 0.92 ALOX5 (0.41) MAPTRORCMMP8MMP3GNRHR
SCHEMBL4840697 0.88 CRHR1 (0.41) MAPTRORCMMP8MMP3IL2
SCHEMBL4837354 0.87 MAPT (0.39) MAPTPSEN1PSEN2APH1BNCSTN
SCHEMBL4833426 0.85 FFAR4 (0.40) MAPTRORCMMP8MMP3GNRHR
SCHEMBL4842178 0.84 PTGER3 (0.37) MAPTRORCMMP8MMP3IL2
SCHEMBL4840740 0.84 FFAR4 (0.39) MAPTRORCMMP8MMP3GNRHR
SCHEMBL4832552 0.83 FFAR4 (0.44) MAPTRORCMMP8MMP3GNRHR
SCHEMBL4838705 0.83 FFAR4 (0.38) MAPTRORCMMP8MMP3GNRHR
SCHEMBL4833262 0.83 ATM (0.38) MAPTRORCMMP8MMP3GNRHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 MAPT 763/4885PSEN1 100/4885PSEN2 309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.